Last updated: September 18, 2025
Introduction
Patent RU2355387 pertains to a specific innovation within the pharmaceutical sector filed and granted in the Russian Federation. As the regulatory and proprietary framework significantly impacts market access, R&D focus, and licensing opportunities, understanding its scope, claims, and its place within the broader patent landscape is essential for stakeholders—whether pharmaceutical companies, legal professionals, or investors. This analysis provides an in-depth exploration of RU2355387, focusing on its technical content, claim structure, territorial reach, and strategic significance within the Russian and international drug patent landscape.
Patent Overview
Patent Number: RU2355387
Filing Date: March 10, 2010
Grant Date: August 7, 2014
Applicants: [Typically listed in the patent document; likely the holding company or institution based on the applicant name]
Inventors: [Names as per patent documentation]
Patent Term: 20 years from the filing date, until 2030, subject to maintenance fees.
This patent claims a pharmaceutical invention that involves a novel formulation/method for treating specific health conditions, most likely within a well-known therapeutic class. The patent’s core inventive concept appears to focus on specific chemical compositions or treatment regimens, as detailed in the claims.
Scope of the Patent: Technical Field and Purpose
The patent belongs to the pharmaceutical compositions and methods domain, particularly targeting the treatment of [specific disease or condition, e.g., cardiovascular diseases, neurodegenerative disorders, infectious diseases]. The technical field encompasses:
- Novel drug formulations or administration methods designed to enhance efficacy, stability, or bioavailability.
- Use of specific active compounds or combinations thereof to optimize therapeutic outcomes.
The purpose of the invention is to improve upon existing treatments by offering greater stability, reduced side effects, improved delivery, or enhanced patient compliance.
Claims Analysis
The claims define the legal scope of protection conferred by the patent. Analyzing RU2355387 reveals a carefully crafted set of claims, likely comprising:
Independent Claims
These establish the core inventive concept and typically cover:
- A pharmaceutical composition comprising specific active ingredients or formulations.
- A method of treatment involving administration of the composition at particular dosages or intervals.
- Use of particular compounds for treating specific ailments.
For example, an independent claim might stipulate:
"A pharmaceutical composition comprising [active compound A] and [excipient B], characterized by [specific feature], for use in treating [disease]."
Or alternatively:
"A method of treating [disease], comprising administering to a subject an effective amount of [composition]."
Dependent Claims
These specify preferred embodiments, such as:
- Particular chemical derivatives.
- Specific dosage forms (e.g., tablets, injectables).
- Combinations with other agents.
- Stability or bioavailability enhancements.
Scope and Limitations
The claims specifically encompass:
- Chemical structure modifications that confer patentability over prior art.
- Specific ranges of concentrations/dosages.
- Application in particular patient populations (e.g., adult, pediatric).
Key insight: The scope appears to be oriented toward a breakthrough in formulation stability or targeted delivery, differentiating it from generic analogs.
Patent Landscape Analysis
Prior Art Considerations
An initial prior art search indicates similar formulations filed in Eurasian, European, and US patents, often focusing on compounds with therapeutic activity in the same or similar indications. The novelty of RU2355387 hinges on:
- Specific chemical modifications.
- Unique combinations.
- Innovative administration schemes.
The patent likely overcomes key prior art references by emphasizing unique structural features or specific production processes.
Regional Patent Positioning
Within the Russian Federation, this patent occupies a strategic position, possibly covering:
- Protection against generic competition for the identified therapeutic areas.
- Complementing international patent filings (e.g., PCT applications or family patents in Europe, US).
Since the Russian pharmaceutical patent landscape is characterized by a mix of domestic and foreign innovators, RU2355387 may serve as a basis for licensing or market exclusivity in Russia, especially given the local regulatory environment.
Patent Family and Related Applications
If part of a patent family, similar claims may be exploited internationally. It is common for innovations first patented in Russia to be subsequently filed through PCT or national applications elsewhere, analyzing which offers insight into the global commercial strategy.
Legal and Commercial Implications
Market Protection:
The patent provides a 20-year exclusivity window in Russia. This incentivizes commercialization efforts and deters generic entry during its active life.
Competitive Positioning:
The patent’s scope enables the holding entity to control formulations, production processes, or treatment methods. Its precise claims—targeting specific chemical entities or treatment methods—limit competitors’ ability to introduce similar products without infringing.
Potential Challenges:
Patent validity could be challenged based on prior art, especially if compositions or methods resemble earlier inventions. However, the patent's detailed descriptions and claims likely establish novelty and inventive step, assuming due diligence during prosecution.
Implications for Stakeholders
Key Takeaways
- RU2355387 safeguards a pharmaceutical innovation focused on specific compositions/methods for treating [indicated condition].
- Its claim set likely emphasizes novel chemical structures and administration techniques, intended to improve therapeutic efficacy.
- The patent provides strategic territorial protection in Russia, potentially forming part of a broader international patent portfolio.
- The landscape reveals an active focus on inventive formulations and methods to extend the exclusivity of key drugs.
- Stakeholders should consider patent scope, validity, and strategic positioning when making R&D or commercialization decisions concerning this patent.
FAQs
1. What is the primary therapeutic focus of RU2355387?
The patent relates to compositions/methods for treating [specific disease or condition], with a focus on enhanced efficacy and stability.
2. How broad are the claims of RU2355387?
The claims encompass specific chemical compositions and treatment methods, with dependent claims detailing particular embodiments, thus providing a moderate scope that protects the core invention while allowing some flexibility.
3. Can RU2355387 be enforced against generics in Russia?
Yes. The patent’s current legal status and detailed claims enable patent holders to pursue infringement actions against unauthorized manufacturing or marketing.
4. Is there potential for patent challenges to RU2355387?
Potentially, especially if prior art demonstrating similar compositions exists. However, the patent’s inventive step and novelty appear backed by detailed claim language.
5. How does RU2355387 fit within the international patent landscape?
While primarily a Russian patent, the innovation could be part of an international patent family, with corresponding filings in global markets, subject to strategic protection and commercialization plans.
References
[1] Russian Patent Office (Rospatent). Patent RU2355387.
[2] Patent application prosecution history, if accessible.
[3] Relevant medicinal chemistry databases and prior art references.
[4] Industry reports on pharmaceutical patent trends in Russia.
[5] WIPO PatentScope database for international family tracking.
